Fundraising Fox

Robert Tansley

Investor

Partner at Cambridge Innovation Capital

Cambridge, United Kingdom

Writes $600K – $6M checks · typically $3.3M

About

Robert Tansley is a trained surgeon-turned-investor who leverages clinical experience, backing major medtechs like CMR Surgical, serving as CMO and translating Cambridge academic research into scalable life sciences companies.

LinkedIn ↗

Invests in

AI & Machine LearningBiotechDeep TechHardwareHealthtechSemiconductors

Experience

  1. MicrobioticaChief Medical Officercurrent2025 — presentCambridge, England, United Kingdom
  2. MicrobioticaBoard Member2016 — 2025Cambridge, United Kingdom
  3. Cambridge Innovation CapitalVenture Partnercurrent2025 — presentCambridge, England, United Kingdom
  4. Cambridge Innovation CapitalPartner2014 — 2025Cambridge, United Kingdom
  5. Pretzel TherapeuticsBoard Membercurrent2021 — presentBoston, MA
  6. Sortera BioBoard Membercurrent2024 — presentCambridge, England, United Kingdom
  7. Sortera BioExecutive Chairperson2024 — 2025Cambridge, England, United Kingdom
  8. BioIndustry Association (BIA)Board Member2023 — 2025London Area, United Kingdom
  9. T-Therapeutics LtdBoard Member2022 — 2025Greater Cambridge Area
  10. ExvastatBoard Member2017 — 2025Cambridge, United Kingdom
  11. PetMedix (acquired by Zoetis)Board Member2020 — 2023Cambridge, England, United Kingdom
  12. ABCODIA LIMITED (acquired by GENinCODE plc)Board Member2015 — 2023
  13. Carrick TherapeuticsBoard Observer2016 — 2022County Dublin, Ireland
  14. CMR SurgicalBoard Member (2016-2019), Board Observer (2019-2021)2016 — 2021Cambridge, United Kingdom
  15. Inivata (acquired by NeoGenomics)Board Member2014 — 2021Cambridge, United Kingdom and Research Park Triangle, NC
  16. MORPHOGEN-IX LIMITED (acquired by Centessa Pharmaceuticals)Board Member2015 — 2021Cambridge, United Kingdom
  17. STORM Therapeutics LimitedBoard Member2015 — 2018Cambridge, United Kingdom
  18. Congenica (acquired by SeqOne)Board Member2015 — 2018Cambridge, United Kingdom
  19. KalVista Pharmaceuticals, Inc. (NASDAQ: KALV)Medical Director2011 — 2015Southampton, UK and Boston, MA
  20. Tansley & TansleyDirector2009 — 2014Cambridge, United Kingdom

Education

  1. University of CambridgeM.Phil, Epidemiology & Biostatistics2004 — 2005
  2. London Business SchoolMBA1998 — 2000
  3. UCLMBBS, Medicine1983 — 1988
  4. Royal College of Obstetricians and GynaecologistsMRCOG
  5. Faculty of Pharmaceutical MedicineDiploma of Pharmaceutical Medicine1996 — 1998

Skills & more

Clinical Development36Pharmacovigilance5Regulatory Affairs10Clinical Trials12GCP4New Business Development2Diabetes7Clinical Research15Oncology7Medicine4Pharmacology4Drug Discovery5
+12 moreBiotechnologyFDADrug DevelopmentInfectious DiseasesR&DPharmaceuticsLifesciencesTherapeutic AreasPharmaceutical IndustryINDTranslational MedicineDermatology

From Robert's professional profile.

Same school

Also attended University of Cambridge621

Niko BonatsosInvestment Team at General CatalystGeorgia StevensonInvestor at Index VenturesHannah SealInvestor at Index VenturesAnthony PhilippakisInvestor at GV (Google Ventures)Erik NordlanderInvestor at GV (Google Ventures)Nic LowdenInvestor at Moonfire Ventures

+ 615 more

Also attended London Business School451

Patrick ClaessenPartner at Cottonwood Technology FundDominic JacquessonInvestor at Index VenturesSandra SchwarzerInvestor at Index VenturesMatt CherianVenture Partner at Monta Vista CapitalAkshat GoenkaInvestor at Moonfire VenturesGiuseppe IademarcoHead of Global Partnership at P101 Ventures

+ 445 more

Also attended UCL253

André DuboisInvestor at Index VenturesFrédérique DameInvestor at GV (Google Ventures)Jonas VetterleInvestor at Moonfire VenturesMarie FerriInvestor at DaphniElena PantaziPartner & Head of Platform at NorthzoneGiovanni MariggiInvestor at Medicxi

+ 247 more

Shared employers

Also worked at Cambridge Innovation Capital15

Damian Crowtherex-AstraZeneca at PICUS CAPITALWilliam Tunstall-PedoeInvestor at Cambridge Innovation CapitalErik LangakerInvestor at Cambridge Innovation CapitalVictoria WoodwardHead of Business Support at Cambridge Innovation CapitalTom PageHead of Investor Relations at Cambridge Innovation CapitalRob SprawsonPartner and CFO at Cambridge Innovation Capital

+ 9 more

Also worked at Sortera Bio1

Dr David LlewellynInvestment committee member at Tin Alley Ventures

Also worked at Carrick Therapeutics3

Caroline GaynorPartner at Lightstone VenturesChristine MartinHead of Ventures at University of Cambridge EnterpriseJason LettmannPartner at Morgenthaler

Also worked at STORM Therapeutics Limited5

Michael AnsteyPartner at Cambridge Innovation CapitalChristine MartinHead of Ventures at University of Cambridge EnterpriseHakan GokerManaging Director at M VenturesSeiji MiyaharaSenior Investment Director at Taiho Ventures, LLCChristopher O'DonnellPartner at Pfizer Venture Investments

Deals · 1

InivataBoard seat

via Cambridge Innovation Capital · filed Jun 2020 · $60M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at Cambridge Innovation Capital

Adam Glinsman
Investor at Cambridge Innovation Capital
Andrew Williamson
Managing Partner at Cambridge Innovation Capital
Andy Neely
Vice Chair at Cambridge Innovation Capital
Andy Richards
Investor at Cambridge Innovation Capital
Anne Horgan
Partner at Cambridge Innovation Capital
Christopher Tapper
Senior Associate at Cambridge Innovation Capital
Damian Crowther
Entrepreneur in Residence at Cambridge Innovation Capital
Dipesh Patel
Operating Partner at Cambridge Innovation Capital

Network1

Andrew Williamson
Managing Partner at Cambridge Innovation Capital

Investors connected to Robert in public investor directories — a warm-intro map.